Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): David Duncker Added: 11 months ago
Prof. David Duncker discusses SCD risk stratification in newly diagnosed heart failure patients View more
Author(s): Carsten W Israel Added: 1 year ago
Join Dr Carsten Israel (Bethel-Clinic, DE) at EHRA 2024 as they discuss SCD Risk Stratification in 2024 – What has Changed With Current GRMT? View more
Author(s): Ilan Goldenberg Added: 1 year ago
Join Dr Ilan Goldenberg (University of Rochester Medical Center, US) at EHRA 2024 as they discuss SCD Risk Stratification in 2024 – What has Changed With Current GRMT? View more
Author(s): José González-Costello Added: 1 year ago
According to Dr José González-Costello (Hospital Universitario de Bellvitge, ES) ESC guideline-directed sudden cardiac death (SCD) risk stratification in patients with newly diagnosed HF is crucial for identifying individuals at high risk of SCD and implementing appropriate preventive strategies. By adhering to ESC guidelines and incorporating patient-specific modalities, clinicians can… View more
Author(s): Catalin Toma Added: 1 year ago
Join Dr Catalin Toma from the University of Pittsburgh School of Medicine as he explores the latest approach to risk stratification in acute pulmonary embolism (PE). Gain insights into defining stages of cardiogenic shock specific to PE and understand the rationale behind early interventions. Dr Toma shares his expertise in managing Intermediate-High and High-Risk PE, emphasising the pivotal role… View more
Author(s): Sripal Bangalore Added: 1 year ago
Gain valuable insights from Prof Sripal Bangalore of New York University School of Medicine (US) on the necessity of updating current risk stratification for acute pulmonary embolism (PE). In this concise video, Prof Bangalore emphasises the significance of the Composite Shock Score, which incorporates predictors of normotensive shock. The aim of this approach is to reduce the mortality rate of… View more
Author(s): Anne Blaes , Dan Lenihan , Joe Carver , et al Start date: Aug 10, 2023
In this month's Journal Club, DrDaniela Cardinale(European Institute of Oncology, Milan, IT), DrAnne Blaes (Masonic Cancer Center, Minneapolis, US),Prof Dan Lenihan(Saint Francis Healthcare System, US) andProf Joe Carver(University of Pennsylvania, US) discuss “Applying the ESC / IC-OS Guidelines: How do we actually do risk stratification?”. The broadcast will explore risk stratification… View more
Author(s): Charalambos Antoniades Added: 1 year ago
AHA 23 — In this brief interview, we are joined by Prof Charalambos Antoniades (Oxford University, UK) to discuss the ORFAN trial, sponsored by the University of Oxford.ORFAN is a prospective, multicenter, observational study that collected CT scans, biological material and outcomes data to develop and validate biomarkers of cardiometabolic risk. The registry included 250000 unselected… View more